INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

103 studies · page 1 of 5

2023 / Review

A review discusses current and emerging anti-obesity medications, including lipase inhibitors, GLP-1 agonists, leptin analogs, and MC4R agonists.

Obesity is a major public health concern associated with conditions like hypertension, type 2 diabetes, stroke, and cancer, affecting over a third of adults in the United States. While standard pharmacological agents such as lipase inhibitors and GLP-1 receptor agonists reduce weight gain by inhibiting fat absorption or stimulating satiety hormones, they are not effective for genetic disorders like Bardet-Biedl syndrome or POMC deficiency. Emerging therapies, including leptin analogs and MC4R agonists, target these genetic or hormonal causes to help regulate energy balance and appetite. The review discusses clinical trials, efficacy, FDA-approved indications, contraindications, and serious side effects of these medication classes.

Brandfon S, Eylon A, Khanna D, et al. Cureus, 2023. PMID 37937009

2020 / Narrative review

Potassium-enriched salt substitutes lower systolic and diastolic blood pressure, but evidence on hyperkalemia risk remains insufficient.

This review evaluated the benefits and risks of replacing sodium chloride with potassium-enriched salt substitutes. Empirical evidence shows that this replacement lowers systolic blood pressure by an average net delta of -5.58 mm Hg (95% CI: -7.08 to -4.09) and diastolic blood pressure by -2.88 mm Hg (95% CI: -3.93 to -1.83). Potential risks include hyperkalemia, arrhythmias, and sudden cardiac death, especially in individuals with impaired potassium excretion such as chronic kidney disease. However, the authors note there is currently insufficient evidence regarding the effects of these substitutes on the occurrence of hyperkalemia.

Greer RC, Marklund M, Anderson CAM, et al. Hypertension, 2020. PMID 31838902

2020 / Narrative review

A review indicates high sodium intake is directly related to increased blood pressure, target organ damage, and elevated cardiovascular risk.

This review examines evidence on sodium intake and target organ damage in hypertension. The authors report that current global sodium consumption exceeds safe levels and that sodium intake is directly related to increased blood pressure and independently to cardiac mass enlargement. High sodium intake may also induce renal damage progression in both hypertensive and normotensive individuals and play an adverse role in cerebrovascular disease.

Nista F, Gatto F, Albertelli M, et al. Int J Environ Res Public Health, 2020. PMID 32325839

2020 / Narrative review

A review notes lifestyle modifications like low sodium diet and weight loss can help control hypertension in African Americans.

This review examined literature from PubMed, guideline reports, and newer publications regarding hypertension and COVID-19 in African Americans. It highlights that the increased prevalence and risks of hypertension are primarily due to environmental and lifestyle factors, such as poor diet and adverse social determinants. Blood pressure control can be supported through lifestyle changes, including a low-sodium diet, weight loss, and physical activity, alongside pharmacological or novel treatments when needed. Additionally, existing comorbidities like hypertension and obesity contribute to worse COVID-19 outcomes in this population.

Ferdinand K, Batieste T, Fleurestil M J Natl Med Assoc, 2020. PMID 32563685

2019 / Narrative review

Increasing potassium intake lowers blood pressure, especially in hypertensive individuals, and reduces stroke risk by about 25%.

This review evaluates evidence on potassium intake for blood pressure control in essential hypertension and its safety in chronic kidney disease. Over 40 years of evidence demonstrates that increasing potassium intake through foods or supplements is associated with significant reductions in systolic and diastolic blood pressure, particularly in hypertensive patients and those with high sodium intake. Meta-analyses confirm high potassium intake reduces stroke risk by ~25%, and post hoc analyses suggest it may slow renal decline in early CKD. However, high potassium intake may be risky in hypertensive patients with CKD stages 3-5, specifically diabetics, though more prospective studies are needed.

Burnier M Nephrol Dial Transplant, 2019. PMID 29301002

2019 / Narrative review

High dietary salt adversely affects target organs including the heart, kidneys, brain, and bone, irrespective of blood pressure.

This review evaluates the blood pressure-independent physiological effects of dietary salt and controversies surrounding lower salt intakes and cardiovascular outcomes. High dietary salt has been shown to adversely affect the vasculature, heart, kidneys, skin, brain, and bone, mediated commonly by heightened inflammation and oxidative stress. The review also addresses the role of background diet in modulating the effects of salt.

Robinson AT, Edwards DG, Farquhar WB Curr Hypertens Rep, 2019. PMID 31025198

2019 / Updated systematic review of meta-analyses

Nut consumption was linked to lower CVD, CHD, and stroke mortality/incidence, and reduced fasting glucose, total cholesterol, and LDL-C in meta-analyses.

An updated electronic search of PubMed/MEDLINE, CINAHL, and Cochrane Library identified seven new meta-analyses examining nut consumption and cardiometabolic diseases. Comparing high with low consumption categories, nut intake significantly decreased CVD mortality (-19% to -25%; n = 4), CHD mortality (-24% to -30%; n = 3), stroke mortality (-17% to -18%; n = 3), CVD incidence (-15% to -19%; n = 4), CHD/CAD incidence (-17% to -34%; n = 8), and stroke incidence (-10% to -11%; n = 6). Compared with control diets, nut consumption significantly reduced fasting glucose (0.08 to 0.15 mmol/L; n = 6), total cholesterol (0.021 to 0.30 mmol/L; n = 10), and LDL-C (0.017 to 0.26 mmol/L; n = 10). Body weight and blood pressure were not significantly affected.

Shows an association, not proof of cause and effect.

Kim Y, Keogh JB, Clifton PM Int J Environ Res Public Health, 2019. PMID 31817639

2019 / Narrative review

A review suggests that a plant-based diet may serve as a valuable tool for managing atrial fibrillation risk factors.

Atrial fibrillation affects an estimated 34 million individuals globally and carries a significant burden of morbidity and mortality. This review examines evidence regarding the use of a whole-food plant-based diet—emphasizing grains, legumes, vegetables, fruits, and nuts while excluding most or all animal products—for managing atrial fibrillation risk factors. It highlights effects on cardiovascular and metabolic factors including hypertension, coronary artery disease, diabetes, obesity, inflammation, and subclinical atherosclerosis.

Storz MA, Helle P J Arrhythm, 2019. PMID 31844466

2018 / Narrative review

Studies report beneficial cardiovascular effects from dietary flaxseed, including antihypertensive, antiatherogenic, and cholesterol-lowering actions.

This review summarizes reported cardiovascular effects of dietary flaxseed supplementation and its bioactive compounds from preclinical and clinical studies. Reported effects have included an antihypertensive action, antiatherogenic effects, a lowering of cholesterol, an anti-inflammatory action, and an inhibition of arrhythmias. These actions have been primarily implicated with its alpha-linolenic acid, secoisolariciresinol diglucoside, and high fiber content, while other compounds such as proteins, cyclolinopeptides, and cyanogenic glycosides may also produce biological actions.

Parikh M, Netticadan T, Pierce GN Am J Physiol Heart Circ Physiol, 2018. PMID 29101172

2018 / Review of randomized controlled trials and other studies

A review indicates caloric restriction can normalize blood pressure and improve arterial stiffness and heart rate variability.

This review evaluated evidence from randomized controlled trials and other studies on caloric restriction (CR) and cardiovascular parameters. CR was found to significantly improve blood pressure (BP), heart rate variability, arterial stiffness, endothelial dysfunction, and flow-mediated arterial dilatation, allowing patients to discontinue antihypertensive medication without becoming hypotensive. Benefits were seen regardless of age, sex, weight, BMI, or metabolic conditions, with the greatest benefits in the sickest individuals. Exercise enhanced the effects of CR only in hypertensive subjects, while proposed mechanisms include improved insulin sensitivity, increased nitric oxide production, and SIRT1 induction.

Nicoll R, Henein MY Int J Mol Sci, 2018. PMID 29518898

2018 / Narrative review

A review reports that vegetarian dietary patterns reduce CVD mortality and coronary heart disease risk by 40%.

This review examined the relationship between vegetarian dietary patterns and cardiovascular disease (CVD). The authors report that vegetarian diets reduce CVD mortality and coronary heart disease (CHD) risk by 40%, and plant-based diets are the only pattern to have shown CHD reversal. Vegetarian and plant-based diets are also associated with lower blood pressure, lower blood lipids, reduced platelet aggregation, weight management benefits, and reduced risk and effective treatment of type 2 diabetes.

Kahleova H, Levin S, Barnard ND Prog Cardiovasc Dis, 2018. PMID 29800598

2018 / Hypothesis / narrative review

A review hypothesizes that low potassium and excessive sodium intakes promote essential hypertension through oxidative stress-induced vascular dysfunction.

The authors hypothesize that the primary environmental determinant of essential hypertension in Westernized countries is low intake of potassium and phytochemicals paired with supraphysiological sodium intake. This dietary pattern is proposed to cause oxidative stress-induced vascular endothelial and smooth muscle dysfunction, reducing nitric oxide bioavailability and raising vascular resistance. The authors note that Americans currently consume potassium-to-sodium in molar ratios under or near 1.0 (IOM recommends 1.2), compared to ancestral diet estimates of 5.0 to 10.0 or higher.

Sebastian A, Cordain L, Frassetto L, et al. Med Hypotheses, 2018. PMID 30122481

2018 / Narrative review

A review summarizes the multifactorial pathogenesis, diagnostic criteria, and genetic variations linked to metabolic syndrome.

This review provides an update on recent literature regarding the epidemiology, diagnostic criteria, and pathogenesis of metabolic syndrome (MetS). MetS involves clinical, metabolic, and biochemical abnormalities including central adiposity, hypertension, insulin resistance, and dyslipidemias, which increase the risk of type 2 diabetes, adverse cardiac events, stroke, and hepatic steatosis. Its pathogenesis is multifactorial, driven by environmental, nutritional, and genetic factors, with chronic low-grade inflammation, visceral adipose tissue, adipocyte dysfunction, and insulin resistance playing major roles.

Shows an association, not proof of cause and effect.

Zafar U, Khaliq S, Ahmad HU, et al. Hormones (Athens), 2018. PMID 30171523

2017 / Scientific statement / evidence review

Evidence links added sugars to increased cardiovascular disease risk factors in children, prompting an AHA recommendation of ≤25 g/day for children.

An American Heart Association writing group reviewed and graded evidence examining the cardiovascular health effects of added sugars in children across five areas: blood pressure, lipids, insulin resistance and diabetes, nonalcoholic fatty liver disease, and obesity. Associations between added sugars and increased cardiovascular disease risk factors among US children are present at levels far below current consumption. Strong evidence supports an association of added sugars with increased cardiovascular disease risk via increased energy intake, adiposity, and dyslipidemia. The committee concluded it is reasonable to recommend children consume ≤25 g (100 cal or ≈6 teaspoons) of added sugars daily and avoid added sugars before 2 years of age.

Shows an association, not proof of cause and effect.

Vos MB, Kaar JL, Welsh JA, et al. Circulation, 2017. PMID 27550974

2017 / Scientific statement / Narrative review

Irregular eating patterns appear less favorable for achieving a healthy cardiometabolic profile.

This American Heart Association scientific statement reviews the cardiometabolic effects of eating patterns such as skipping breakfast, intermittent fasting, meal frequency, and timing. It also proposes definitions for meals, snacks, and eating occasions for research. Findings suggest that irregular eating patterns appear less favorable for cardiometabolic health, whereas intentional eating focused on timing and frequency may support healthier cardiometabolic risk management.

Shows an association, not proof of cause and effect.

St-Onge MP, Ard J, Baskin ML, et al. Circulation, 2017. PMID 28137935

2017 / Narrative review

Vegetarian diets are linked to lower type 2 diabetes prevalence and shown to improve glycemic control, weight, lipids, and blood pressure.

This article reviews epidemiological and interventional studies on vegetarian diets for the prevention and management of type 2 diabetes. Epidemiological studies demonstrate a lower prevalence of type 2 diabetes among vegetarians compared to nonvegetarians. Interventional studies indicate that vegetarian diets, especially vegan diets, control plasma glucose more effectively than control diets, including traditionally recommended diets like carbohydrate counting. Furthermore, vegetarian diets are linked with improvements in secondary outcomes including weight reduction, serum lipid profile, and blood pressure.

Pawlak R Diabetes Spectr, 2017. PMID 28588373

2017 / Narrative review

Dietary omega-3 fatty acids can alter oxylipin profiles with potential benefits for cardiovascular disease and aging-related degeneration.

This review examines how oxylipins, fatty acid metabolites derived from polyunsaturated fatty acids, relate to cardiovascular disease and aging. Oxylipins from arachidonic acid and linoleic acid generally promote inflammation, hypertension, or adverse cardiovascular effects, whereas oxylipins from 20- and 22-carbon omega-3 fatty acids show anti-inflammatory and vasodilatory effects. In clinical trials, flaxseed supplementation indicated positive effects on blood pressure via alpha-linolenic acid oxylipins. A small number of human and animal trials suggest dietary omega-3 interventions might help slow normal aging-related tissue changes.

Caligiuri SPB, Parikh M, Stamenkovic A, et al. Am J Physiol Heart Circ Physiol, 2017. PMID 28801523

2017 / Scientific statement / narrative review

A higher prevalence of risk factors such as hypertension, diabetes, and obesity underlies earlier onset of cardiovascular disease in African Americans.

This American Heart Association scientific statement reviewed literature from PubMed/Medline and the CDC regarding cardiovascular health disparities in African Americans. Traditional risk factors including hypertension, diabetes mellitus, obesity, and atherosclerotic cardiovascular risk show higher prevalence and earlier disease onset in this population. Hypertension notably contributes to disparities in stroke, heart failure, and peripheral artery disease, while disease management remains less effective. The statement emphasizes that addressing these multifactorial disparities requires strategies involving diverse stakeholders.

Shows an association, not proof of cause and effect.

Carnethon MR, Pu J, Howard G, et al. Circulation, 2017. PMID 29061565

2016 / Comprehensive narrative review

Dietary potassium supplementation offers favorable effects on blood pressure, stroke risk, bone health, and kidney stone risk.

Authors reviewed literature from 1980 to 2015 via PubMed and MEDLINE covering potassium intake, renal excretion, and hyperkalemia prevention. Potassium deficiency is implicated in cardiovascular disease, kidney stones, and osteoporosis, whereas supplementation reduces blood pressure, stroke risk, and nephrolithiasis risk while improving bone health. The review details gastrointestinal and renal mechanisms regulating potassium homeostasis, and discusses gastrointestinal potassium-binding drugs that may permit diet liberalization in patients at risk of hyperkalemia.

Palmer BF, Clegg DJ Mayo Clin Proc, 2016. PMID 26948054

2016 / Narrative review

A review indicates RCTs and cohort studies on diet and disease sometimes conflict due to differences in participant risk profiles and follow-up durations.

This narrative review examined eight sets of dietary studies, comparing findings between randomised controlled trials (RCTs) and epidemiological studies (mostly cohort studies) covering blood pressure, body weight, cancer, and heart disease. While some study findings were consistent, others conflicted. The review noted that RCTs frequently enroll high-risk participants or those with disease history and follow them for only weeks or months, whereas cohort studies typically follow healthy subjects for 5 to 15 years. Consequently, RCT findings are not necessarily more reliable than well-designed prospective cohort studies.

Temple NJ Br J Nutr, 2016. PMID 27267302

2016 / Narrative review

Irregular meal patterns are linked to higher cardiometabolic risk, while regular eating improved insulin and cholesterol in two intervention trials.

This narrative review evaluated observational and intervention studies on irregular meal patterns and cardiometabolic consequences. Few observational studies were found, but most suggested eating meals irregularly is associated with a higher risk of metabolic syndrome and cardiometabolic risk factors such as BMI and blood pressure. Additionally, two randomized controlled trials found that consuming meals regularly for 2 weeks versus an irregular pattern led to lower peak insulin and lower fasting total and LDL-cholesterol in lean and obese women. The authors noted the evidence is limited and highlighted the need for more large-scale studies with detailed dietary assessments.

Pot GK, Almoosawi S, Stephen AM Proc Nutr Soc, 2016. PMID 27327128

2016 / Narrative review

Energy drink cardiovascular responses appear primarily driven by caffeine and sugar, though other active ingredients cannot be fully ruled out.

This review examines the potential adverse hemodynamic effects of energy drinks, focusing on blood pressure and heart rate. Most studies in the general population report effects on these variables, though inconsistencies in methodologies, ingested volumes, and measurement durations complicate firm conclusions. Recent randomized crossover trials using continuous beat-to-beat measurements indicate cardiovascular responses are best explained by caffeine and sugar, with minimal influence from other ingredients, though roles for constituents like taurine and glucuronolactone cannot be excluded.

Grasser EK, Miles-Chan JL, Charrière N, et al. Adv Nutr, 2016. PMID 27633110

2016 / Position statement

Appropriately planned vegetarian and vegan diets are healthful, nutritionally adequate, and linked to reduced risks of certain chronic diseases.

The Academy of Nutrition and Dietetics states that appropriately planned vegetarian, including vegan, diets are healthful, nutritionally adequate, and appropriate for all stages of the life cycle and athletes. Vegetarians and vegans have a reduced risk of conditions such as ischemic heart disease, type 2 diabetes, hypertension, certain cancers, and obesity. Diets low in saturated fat and high in vegetables, fruits, whole grains, legumes, soy, nuts, and seeds yield lower total and LDL cholesterol and improved glucose control. The position statement notes that vegans require reliable sources of vitamin B-12 from fortified foods or supplements.

Melina V, Craig W, Levin S J Acad Nutr Diet, 2016. PMID 27886704

2015 / Narrative review of acute and long-term feeding studies and meta-analyses

Higher-protein diets of 1.2 to 1.6 g/kg/d improve weight management, appetite control, and cardiometabolic risk factors, especially with dietary compliance.

This review examines literature on mechanisms following acute protein consumption and clinical outcomes from long-term, higher-protein diets. Meta-analyses of shorter-term, tightly controlled feeding studies showed greater weight loss, fat mass loss, lean mass preservation, and reductions in triglycerides, blood pressure, and waist circumference with higher-protein diets. Acute trials confirmed modest satiety effects without affecting energy intake at the next meal, while longer-term studies yielded conflicting findings largely driven by dietary compliance. The evidence suggests diets containing 1.2 to 1.6 g protein · kg-1 · d-1 (with at least ~25-30 g/meal) provide improvements in appetite, weight management, and cardiometabolic factors.

Leidy HJ, Clifton PM, Astrup A, et al. Am J Clin Nutr, 2015. PMID 25926512